An increase in HRAS mutations was also reported (6.9% for UTUC; 2.8%, for BUC), with most of the HRAS-altered tumours arising from UTUC of the renal pelvis rather than from other anatomic sites. The gene discussed is HRAS; the disease is neoplasm.